Targeting phosphoinositide 3-kinases and histone deacetylases in multiple myeloma

BACKGROUND: Multiple myeloma (MM) is a type of hematological malignancy affecting the functions of plasma cells. The treatment of MM patients has changed dramatically with the use of new agents. However, unfortunately, it is still incurable. Therefore, a new approach for treating MM is still needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Okabe, Seiichi, Tanaka, Yuko, Gotoh, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934550/
https://www.ncbi.nlm.nih.gov/pubmed/33663586
http://dx.doi.org/10.1186/s40164-021-00213-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934550/
https://www.ncbi.nlm.nih.gov/pubmed/33663586
http://dx.doi.org/10.1186/s40164-021-00213-6

Ejemplares similares